A randomized, placebo-controlled trial of certolizumab pegol (CDP870) for treatment of Crohn's disease (Q28270722)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized, placebo-controlled trial of certolizumab pegol (CDP870) for treatment of Crohn's disease |
scientific article |
Statements
A randomized, placebo-controlled trial of certolizumab pegol (CDP870) for treatment of Crohn's disease (English)
0 references
September 2005
0 references
129
0 references
3
0 references
807-18
0 references